Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Lonafarnib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
    Sentynl Acquires Zokinvy® For Progeria From Eiger Globally

    03 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sentynl-therapeutics-announces-global-acquisition-of-zokinvy-lonafarnib-for-treatment-of-hutchinson-gilford-progeria-syndrome-from-eiger-biopharmaceuticals-302135968.html

    PR NEWSWIRE
    03 May 2024
    Share Share
    Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
    Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year

    02 Apr 2024

    // BIOSPACE

    https://www.biospace.com/article/eiger-files-for-bankruptcy-plans-to-shutter-operations-after-difficult-year/

    BIOSPACE
    02 Apr 2024
    Share Share
    Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
    Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

    01 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/01/2855277/0/en/Eiger-BioPharmaceuticals-Files-for-Voluntary-Chapter-11-Protection.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson
    Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson

    18 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eiger-and-partner-anges-receive-approval-for-zokinvy-lonafarnib-for-hutchinson--gilford-progeria-syndrome-and-processing-deficient-progeroid-laminopathies-in-japan-302038919.html

    PR NEWSWIRE
    18 Jan 2024
    Share Share
    EigerBio's Zokinvy (lonafarnib) Receives Approval in Europe
    EigerBio's Zokinvy (lonafarnib) Receives Approval in Europe

    24 Mar 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/zokinvy-epar-medicine-overview_en.pdf

    EMA
    24 Mar 2023
    Share Share
    Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib
    Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib

    07 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-host-conference-call-to-discuss-phase-3-d-livr-study-results-of-lonafarnib-based-treatments-in-hepatitis-delta-virus-hdv-on-thursday-december-8-2022-301697555.html

    PRNEWSWIRE
    07 Dec 2022
    Share Share